| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG3 CACNA1E SLC25A18 PIEZO1 SLC2A14 GLRA3 CEACAM6 SLC39A4 SLC12A8 NDUFB5 SLC1A2 SLC22A6 SLC7A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM APOL3 NIPAL1 SLC9A7 SLC25A44 DISP2 NIPA2 SLC14A2 MFSD10 | 1.26e-07 | 1180 | 147 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRG3 CACNA1E SLC25A18 PIEZO1 SLC2A14 GLRA3 CEACAM6 SLC39A4 SLC12A8 NDUFB5 SLC1A2 SLC22A6 SLC7A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM APOL3 NIPAL1 SLC9A7 SLC25A44 DISP2 NIPA2 SLC14A2 MFSD10 | 7.25e-07 | 1289 | 147 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG3 CACNA1E SLC25A18 GLRA3 SLC39A4 SLC12A8 NDUFB5 SLC1A2 SLC22A6 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM APOL3 NIPAL1 SLC9A7 NIPA2 | 3.12e-06 | 758 | 147 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG3 CACNA1E SLC25A18 PIEZO1 GLRA3 SLC39A4 SLC12A8 NDUFB5 SLC1A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM APOL3 NIPAL1 SLC9A7 NIPA2 | 5.97e-06 | 793 | 147 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A18 SLC2A14 CEACAM6 SLC39A4 SLC1A2 SLC22A6 SLC7A2 MFSD2A SLC5A6 SLC25A44 MFSD10 | 1.14e-05 | 293 | 147 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC25A18 SLC39A4 SLC12A8 NDUFB5 SLC1A2 MFSD2A ATP2C1 SLC41A3 SLC5A6 GHITM SLC9A7 | 1.46e-05 | 301 | 147 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E SLC25A18 PIEZO1 SLC39A4 SLC12A8 NDUFB5 SLC1A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM NIPAL1 SLC9A7 NIPA2 | 3.20e-05 | 664 | 147 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E SLC39A4 SLC12A8 SLC1A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM NIPAL1 SLC9A7 NIPA2 | 4.11e-05 | 465 | 147 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 4.52e-05 | 10 | 147 | 3 | GO:0008641 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E SLC25A18 SLC39A4 SLC12A8 NDUFB5 SLC1A2 MFSD2A ATP2C1 KCNA4 SLC41A3 SLC5A6 GHITM NIPAL1 SLC9A7 NIPA2 | 6.20e-05 | 627 | 147 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A18 SLC39A4 SLC12A8 SLC1A2 SLC22A6 MFSD2A SLC41A3 SLC5A6 GHITM SLC9A7 | 7.00e-05 | 296 | 147 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC25A18 CEACAM6 SLC1A2 SLC22A6 SLC7A2 MFSD2A SLC5A6 SLC25A44 | 1.52e-04 | 207 | 147 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC25A18 CEACAM6 SLC1A2 SLC22A6 SLC7A2 MFSD2A SLC5A6 SLC25A44 | 1.57e-04 | 208 | 147 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 1.61e-04 | 3 | 147 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A18 SLC39A4 SLC12A8 NDUFB5 SLC1A2 SLC22A6 MFSD2A ATP2C1 SLC41A3 SLC5A6 GHITM SLC9A7 | 2.19e-04 | 477 | 147 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.31e-04 | 41 | 147 | 4 | GO:0016877 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.52e-04 | 119 | 147 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 2.94e-04 | 18 | 147 | 3 | GO:0015095 | |
| GeneOntologyMolecularFunction | ubiquitin activating enzyme activity | 3.20e-04 | 4 | 147 | 2 | GO:0004839 | |
| GeneOntologyMolecularFunction | neuregulin binding | 7.92e-04 | 6 | 147 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | symporter activity | 8.62e-04 | 150 | 147 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.92e-04 | 151 | 147 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.69e-03 | 171 | 147 | 6 | GO:0015103 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1E SLC39A4 SLC12A8 WNK1 SLC1A2 SLC7A2 PER2 SLC5A6 SLC9A7 WNK2 | 6.91e-06 | 230 | 149 | 10 | GO:0098739 |
| GeneOntologyCellularComponent | synaptic membrane | GABRG3 CACNA1E ERBB3 ERBB4 SIGMAR1 SLC2A14 GLRA3 LRRTM3 MAGEE1 CSMD2 SLC1A2 PTPRA KCNA4 PTPRZ1 LRFN5 SLITRK5 SCRIB ENO2 | 2.11e-07 | 583 | 150 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRG3 CACNA1E ERBB3 ERBB4 SIGMAR1 GLRA3 LRRTM3 MAGEE1 CSMD2 KCNA4 PTPRZ1 LRFN5 SLITRK5 SCRIB | 1.38e-06 | 405 | 150 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.52e-05 | 201 | 150 | 9 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.81e-05 | 157 | 150 | 8 | GO:0098839 | |
| Domain | E1_4HB | 4.68e-07 | 3 | 146 | 3 | PF16191 | |
| Domain | E1_FCCH | 4.68e-07 | 3 | 146 | 3 | PF16190 | |
| Domain | UBQ-activ_enz_E1 | 4.68e-07 | 3 | 146 | 3 | IPR018075 | |
| Domain | UBA_e1_C | 4.68e-07 | 3 | 146 | 3 | SM00985 | |
| Domain | Ub-activating_enz_E1_C | 4.68e-07 | 3 | 146 | 3 | IPR018965 | |
| Domain | E1_4HB | 4.68e-07 | 3 | 146 | 3 | IPR032420 | |
| Domain | E1_FCCH | 4.68e-07 | 3 | 146 | 3 | IPR032418 | |
| Domain | E1_UFD | 4.68e-07 | 3 | 146 | 3 | PF09358 | |
| Domain | - | 1.86e-06 | 4 | 146 | 3 | 1.10.3240.10 | |
| Domain | UBIQUITIN_ACTIVAT_1 | 4.63e-06 | 5 | 146 | 3 | PS00536 | |
| Domain | UBA_E1_Cys | 4.63e-06 | 5 | 146 | 3 | IPR019572 | |
| Domain | UBIQUITIN_ACTIVAT_2 | 4.63e-06 | 5 | 146 | 3 | PS00865 | |
| Domain | UBA_e1_thiolCys | 4.63e-06 | 5 | 146 | 3 | PF10585 | |
| Domain | UBQ/SUMO-activ_enz_E1-like | 9.20e-06 | 6 | 146 | 3 | IPR000011 | |
| Domain | ThiF_NAD_FAD-bd | 5.39e-05 | 10 | 146 | 3 | IPR000594 | |
| Domain | ThiF | 5.39e-05 | 10 | 146 | 3 | PF00899 | |
| Domain | Furin_repeat | 3.50e-04 | 18 | 146 | 3 | IPR006212 | |
| Domain | FU | 3.50e-04 | 18 | 146 | 3 | SM00261 | |
| Domain | UBQ-activ_enz_E1_CS | 3.60e-04 | 4 | 146 | 2 | IPR018074 | |
| Domain | UBQ-activ_enz_E1_Cys_AS | 3.60e-04 | 4 | 146 | 2 | IPR033127 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 3.60e-04 | 4 | 146 | 2 | IPR016245 | |
| Domain | HEMATOPO_REC_L_F3 | 5.98e-04 | 5 | 146 | 2 | PS01354 | |
| Domain | Hematopoietin_rcpt_L_F3_CS | 5.98e-04 | 5 | 146 | 2 | IPR003530 | |
| Domain | OSR1_C | 8.92e-04 | 6 | 146 | 2 | PF12202 | |
| Domain | GF_recep_IV | 8.92e-04 | 6 | 146 | 2 | PF14843 | |
| Domain | GF_recep_IV | 8.92e-04 | 6 | 146 | 2 | IPR032778 | |
| Domain | Mg_trans_NIPA | 8.92e-04 | 6 | 146 | 2 | IPR008521 | |
| Domain | Mg_trans_NIPA | 8.92e-04 | 6 | 146 | 2 | PF05653 | |
| Domain | Kinase_OSR1/WNK_CCT | 8.92e-04 | 6 | 146 | 2 | IPR024678 | |
| Domain | DHHC | 9.49e-04 | 25 | 146 | 3 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 9.49e-04 | 25 | 146 | 3 | IPR001594 | |
| Domain | FN3 | 9.77e-04 | 199 | 146 | 7 | PS50853 | |
| Domain | Recep_L_domain | 1.24e-03 | 7 | 146 | 2 | PF01030 | |
| Domain | ApoL | 1.24e-03 | 7 | 146 | 2 | PF05461 | |
| Domain | Furin-like | 1.24e-03 | 7 | 146 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.24e-03 | 7 | 146 | 2 | IPR000494 | |
| Domain | ApoL | 1.24e-03 | 7 | 146 | 2 | IPR008405 | |
| Domain | Furin-like_Cys-rich_dom | 1.24e-03 | 7 | 146 | 2 | IPR006211 | |
| Domain | - | 1.24e-03 | 7 | 146 | 2 | 3.80.20.20 | |
| Domain | FN3_dom | 1.30e-03 | 209 | 146 | 7 | IPR003961 | |
| Domain | Helicase/UvrB_N | 1.65e-03 | 8 | 146 | 2 | IPR006935 | |
| Domain | ResIII | 1.65e-03 | 8 | 146 | 2 | PF04851 | |
| Domain | CTLH | 2.11e-03 | 9 | 146 | 2 | SM00668 | |
| Domain | CTLH_C | 2.62e-03 | 10 | 146 | 2 | IPR006595 | |
| Domain | CTLH | 2.62e-03 | 10 | 146 | 2 | PS50897 | |
| Domain | LRR_TYP | 2.70e-03 | 177 | 146 | 6 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.70e-03 | 177 | 146 | 6 | IPR003591 | |
| Domain | LAM_G_DOMAIN | 3.23e-03 | 38 | 146 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 3.74e-03 | 40 | 146 | 3 | PF02210 | |
| Domain | L_dom-like | 4.32e-03 | 328 | 146 | 8 | IPR032675 | |
| Domain | SSD | 4.47e-03 | 13 | 146 | 2 | IPR000731 | |
| Domain | SSD | 4.47e-03 | 13 | 146 | 2 | PS50156 | |
| Domain | LamG | 4.90e-03 | 44 | 146 | 3 | SM00282 | |
| Domain | LRR | 5.03e-03 | 201 | 146 | 6 | PS51450 | |
| Domain | ARM-type_fold | 5.25e-03 | 339 | 146 | 8 | IPR016024 | |
| Domain | Cys-rich_flank_reg_C | 5.44e-03 | 90 | 146 | 4 | IPR000483 | |
| Domain | LRRCT | 5.44e-03 | 90 | 146 | 4 | SM00082 | |
| Domain | - | IL11RA HLA-DRB4 OBSCN CEACAM6 PIGR PTPRZ1 LRFN5 ATF7IP CTLA4 HCFC1 PLXNA2 CNTFR | 5.90e-03 | 663 | 146 | 12 | 2.60.40.10 |
| Domain | - | 6.58e-03 | 95 | 146 | 4 | 2.60.120.200 | |
| Domain | LRRNT | 7.34e-03 | 98 | 146 | 4 | IPR000372 | |
| Domain | LRRNT | 7.34e-03 | 98 | 146 | 4 | SM00013 | |
| Domain | LRR_1 | 7.56e-03 | 219 | 146 | 6 | PF00560 | |
| Domain | Growth_fac_rcpt_ | 7.66e-03 | 156 | 146 | 5 | IPR009030 | |
| Pubmed | MBTPS1 FRAS1 IFT172 VPS8 GON4L CEP192 WDR47 YEATS2 PER2 UBR5 PRRC2C DISP2 MTCL1 SCRIB PLXNA2 PDZD2 | 3.36e-11 | 407 | 151 | 16 | 12693553 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | GPAA1 ACO2 SLC39A4 DHRS1 MFSD2A ATP2C1 PTPRA TM9SF2 SLC41A3 SLC5A6 GHITM SLC9A7 NIPA2 SCRIB SETD3 SAP130 MFSD10 | 1.13e-08 | 697 | 151 | 17 | 28298427 |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 5.47e-06 | 101 | 151 | 6 | 23382219 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 PIEZO1 OBSCN ZDHHC5 CEP192 WNK1 ZDHHC8 LYST KMT2C TKFC PER2 ARVCF CSAD DISP2 HCFC1 WNK2 SYMPK | 6.78e-06 | 1105 | 151 | 17 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBTPS1 HIF1A RTEL1 SIGMAR1 OBSCN CEP192 NDUFB5 YEATS2 KMT2C LRPPRC ATP2C1 BRI3BP SLC41A3 ANKAR UBA6 SLC9A7 PNPLA7 SAP130 WNK2 PDZD2 | 7.52e-06 | 1489 | 151 | 20 | 28611215 |
| Pubmed | 9.41e-06 | 10 | 151 | 3 | 19298847 | ||
| Pubmed | CACNA1E ERBB4 SLC25A18 SLC2A14 LRRTM3 DHRS1 ZDHHC8 SLC1A2 PTPRA ARVCF | 1.20e-05 | 405 | 151 | 10 | 38187761 | |
| Pubmed | Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland. | 1.87e-05 | 2 | 151 | 2 | 24966332 | |
| Pubmed | Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis. | 1.87e-05 | 2 | 151 | 2 | 24642341 | |
| Pubmed | Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. | 1.87e-05 | 2 | 151 | 2 | 26745281 | |
| Pubmed | Identification and characteristics of a novel E1 like gene nUBE1L in human testis. | 1.87e-05 | 2 | 151 | 2 | 15202508 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 35442829 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22999844 | ||
| Pubmed | The upgraded role of HER3 and HER4 receptors in breast cancer. | 1.87e-05 | 2 | 151 | 2 | 19481955 | |
| Pubmed | Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients. | 1.87e-05 | 2 | 151 | 2 | 26254096 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25049274 | ||
| Pubmed | The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. | 1.87e-05 | 2 | 151 | 2 | 22674301 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 32315024 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 17969526 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 37827154 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15055474 | ||
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 1.87e-05 | 2 | 151 | 2 | 35849656 | |
| Pubmed | Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling. | 1.87e-05 | 2 | 151 | 2 | 22308027 | |
| Pubmed | Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. | 1.87e-05 | 2 | 151 | 2 | 18182100 | |
| Pubmed | Muscle stem cell fate is controlled by the cell-polarity protein Scrib. | 1.87e-05 | 2 | 151 | 2 | 25704816 | |
| Pubmed | YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration. | 1.87e-05 | 2 | 151 | 2 | 32749678 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27536774 | ||
| Pubmed | Protein tyrosine-phosphatase expression profiling in gastric cancer tissues. | 1.87e-05 | 2 | 151 | 2 | 16338072 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25451255 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30885992 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31400925 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28851073 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19390858 | ||
| Pubmed | CACNA1E SLC1A2 WDR47 LRPPRC UBA1 SF3B1 KCNA4 ARVCF UBR5 PRRC2C ATF7IP UBA6 MTCL1 SCRIB WNK2 | 2.11e-05 | 963 | 151 | 15 | 28671696 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | ACO2 CAMLG YEATS2 KMT2C TKFC TM9SF2 PRRC2C GHITM SAP130 ALDH7A1 | 3.35e-05 | 457 | 151 | 10 | 32344865 |
| Pubmed | Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15. | 4.31e-05 | 16 | 151 | 3 | 24984263 | |
| Pubmed | Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients. | 5.60e-05 | 3 | 151 | 2 | 23712355 | |
| Pubmed | Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development. | 5.60e-05 | 3 | 151 | 2 | 12112465 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 23003343 | ||
| Pubmed | Dendritic cell Piezo1 directs the differentiation of TH1 and Treg cells in cancer. | 5.60e-05 | 3 | 151 | 2 | 35993548 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 9671661 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 30637799 | ||
| Pubmed | The mechanosensitive ion channel PIEZO1 promotes satellite cell function in muscle regeneration. | 5.60e-05 | 3 | 151 | 2 | 36446523 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 9851845 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 26770020 | ||
| Pubmed | Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy. | 5.60e-05 | 3 | 151 | 2 | 26927669 | |
| Pubmed | Wnk kinases are positive regulators of canonical Wnt/β-catenin signalling. | 5.60e-05 | 3 | 151 | 2 | 23797875 | |
| Pubmed | Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines. | 5.60e-05 | 3 | 151 | 2 | 11464862 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 28304405 | ||
| Pubmed | Expression and significance of HER family receptors in neuroblastic tumors. | 5.60e-05 | 3 | 151 | 2 | 21203803 | |
| Pubmed | Palmitoylation by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R trafficking. | 5.60e-05 | 3 | 151 | 2 | 22325201 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 19801377 | ||
| Pubmed | High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. | 5.60e-05 | 3 | 151 | 2 | 24901400 | |
| Pubmed | The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1. | 5.60e-05 | 3 | 151 | 2 | 38599542 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 28653892 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 35796937 | ||
| Pubmed | Uncommon somatic mutations in metastatic NUT midline carcinoma. | 5.60e-05 | 3 | 151 | 2 | 28967088 | |
| Pubmed | An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. | 5.60e-05 | 3 | 151 | 2 | 11867753 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 22891299 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 7689552 | ||
| Pubmed | ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. | 5.60e-05 | 3 | 151 | 2 | 23333248 | |
| Pubmed | Expression and potential role of ErbB receptors in type II endometrial cancer. | 5.60e-05 | 3 | 151 | 2 | 23395558 | |
| Pubmed | A novel model for extrapleural cavity metastasis assessment in patients with lung cancer. | 5.60e-05 | 3 | 151 | 2 | 33709781 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 30554580 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 31976761 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 9516479 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 9565587 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 37700277 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 18424286 | ||
| Pubmed | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | 5.60e-05 | 3 | 151 | 2 | 25731189 | |
| Pubmed | Functional characterization of NIPA2, a selective Mg2+ transporter. | 5.60e-05 | 3 | 151 | 2 | 18667602 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 27779915 | ||
| Pubmed | 8.18e-05 | 101 | 151 | 5 | 10997877 | ||
| Pubmed | Motor neurons control blood vessel patterning in the developing spinal cord. | 1.01e-04 | 21 | 151 | 3 | 28262664 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 16685269 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 1.12e-04 | 4 | 151 | 2 | 24557338 | |
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 1.12e-04 | 4 | 151 | 2 | 23991224 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 11425901 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 26648299 | ||
| Pubmed | Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers. | 1.12e-04 | 4 | 151 | 2 | 19148499 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 22327010 | ||
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 1.12e-04 | 4 | 151 | 2 | 11571656 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 17177598 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 11498583 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 21203579 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 17983831 | ||
| Pubmed | Per1/Per2-Igf2 axis-mediated circadian regulation of myogenic differentiation. | 1.12e-04 | 4 | 151 | 2 | 34009269 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 17579610 | ||
| Pubmed | Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer. | 1.12e-04 | 4 | 151 | 2 | 26560853 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 19447869 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 18985033 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 18940880 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 34384519 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 28134249 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 22854050 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 9771475 | ||
| Pubmed | IRS4, a novel modulator of BMP/Smad and Akt signalling during early muscle differentiation. | 1.12e-04 | 4 | 151 | 2 | 28821740 | |
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 1.12e-04 | 4 | 151 | 2 | 20204273 | |
| Pubmed | HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. | 1.12e-04 | 4 | 151 | 2 | 26083752 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 15733067 | ||
| Interaction | YIPF3 interactions | GPAA1 SIGMAR1 FFAR1 PIEZO1 P2RY8 NDUFB5 SLC7A2 BRI3BP SLC5A6 NIPAL1 NIPA2 | 1.14e-07 | 186 | 146 | 11 | int:YIPF3 |
| GeneFamily | Solute carriers | SLC25A18 SLC2A14 SLC39A4 SLC12A8 SLC1A2 SLC22A6 SLC7A2 SLC41A3 SLC5A6 SLC9A7 SLC25A44 SLC14A2 | 1.20e-06 | 395 | 96 | 12 | 752 |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.69e-05 | 10 | 96 | 3 | 100 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 1.66e-04 | 4 | 96 | 2 | 1096 | |
| GeneFamily | Fibronectin type III domain containing | 1.63e-03 | 160 | 96 | 5 | 555 | |
| GeneFamily | ATAC complex | 2.09e-03 | 13 | 96 | 2 | 1058 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | NPR2 PIEZO1 OBSCN WNK1 DHRS1 SLC1A2 PIGZ SIAH3 SLC41A3 PAPPA | 6.94e-09 | 139 | 148 | 10 | M9006 |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 8.87e-06 | 85 | 148 | 6 | M41085 | |
| Coexpression | GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP | 1.89e-05 | 200 | 148 | 8 | M4541 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.58e-08 | 200 | 149 | 9 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.28e-08 | 166 | 149 | 8 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.28e-08 | 166 | 149 | 8 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.28e-08 | 166 | 149 | 8 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-07 | 194 | 149 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-07 | 195 | 149 | 8 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-07 | 196 | 149 | 8 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.44e-07 | 197 | 149 | 8 | e2c820c4e4a6cd01ceb020473286e3f5d4e3718e | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-07 | 199 | 149 | 8 | eb2d1b7e875c5bf833e7a80b43282e12893c34e9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-07 | 200 | 149 | 8 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 164 | 149 | 7 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.03e-06 | 174 | 149 | 7 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-06 | 181 | 149 | 7 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-06 | 181 | 149 | 7 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 181 | 149 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 181 | 149 | 7 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 181 | 149 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 182 | 149 | 7 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.04e-06 | 185 | 149 | 7 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-06 | 187 | 149 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.38e-06 | 188 | 149 | 7 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 189 | 149 | 7 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-06 | 190 | 149 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.63e-06 | 190 | 149 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-06 | 190 | 149 | 7 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.63e-06 | 190 | 149 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | COVID-19_Severe-Neu_3|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 3.68e-06 | 123 | 149 | 6 | 4c20c025b6f19f075a13282288fc537e6e186217 | |
| ToppCell | COVID-19_Severe-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 3.86e-06 | 124 | 149 | 6 | 54b42ffb161eece4ae308782e43a0e0dc360281e | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-06 | 195 | 149 | 7 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-06 | 195 | 149 | 7 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-06 | 195 | 149 | 7 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.30e-06 | 195 | 149 | 7 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 4.45e-06 | 196 | 149 | 7 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-06 | 196 | 149 | 7 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.45e-06 | 196 | 149 | 7 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-06 | 196 | 149 | 7 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.45e-06 | 196 | 149 | 7 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.45e-06 | 196 | 149 | 7 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.45e-06 | 196 | 149 | 7 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.45e-06 | 196 | 149 | 7 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.60e-06 | 197 | 149 | 7 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 198 | 149 | 7 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 198 | 149 | 7 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 198 | 149 | 7 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.92e-06 | 199 | 149 | 7 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 199 | 149 | 7 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.92e-06 | 199 | 149 | 7 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 199 | 149 | 7 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | distal-Epithelial-Mucous-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.92e-06 | 199 | 149 | 7 | 35fb7bd35e53d8ca189fe8c7744211a5201081f6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.92e-06 | 199 | 149 | 7 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.08e-06 | 200 | 149 | 7 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 200 | 149 | 7 | de55100e98d3e9b8a74e37aebcd3afa2b0996527 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.08e-06 | 200 | 149 | 7 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 5.08e-06 | 200 | 149 | 7 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-06 | 200 | 149 | 7 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.08e-06 | 200 | 149 | 7 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.09e-06 | 141 | 149 | 6 | 73b3e967357cba7585d97ec9e9d48d3e94ebe31e | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-05 | 152 | 149 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-05 | 157 | 149 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.66e-05 | 160 | 149 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.66e-05 | 160 | 149 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 162 | 149 | 6 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 162 | 149 | 6 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 162 | 149 | 6 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 162 | 149 | 6 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 163 | 149 | 6 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-05 | 166 | 149 | 6 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 167 | 149 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.12e-05 | 167 | 149 | 6 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 169 | 149 | 6 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 169 | 149 | 6 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 169 | 149 | 6 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 169 | 149 | 6 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.26e-05 | 169 | 149 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.58e-05 | 173 | 149 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 173 | 149 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-05 | 173 | 149 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 174 | 149 | 6 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.67e-05 | 174 | 149 | 6 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 174 | 149 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 174 | 149 | 6 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | ASK452-Epithelial-Secretory|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.84e-05 | 176 | 149 | 6 | dd334c8a8a31dc26b2d558df0ef6bed6dc1a6610 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 177 | 149 | 6 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.03e-05 | 178 | 149 | 6 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-05 | 178 | 149 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 178 | 149 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.03e-05 | 178 | 149 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-05 | 180 | 149 | 6 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 181 | 149 | 6 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 181 | 149 | 6 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.43e-05 | 182 | 149 | 6 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.43e-05 | 182 | 149 | 6 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 182 | 149 | 6 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| Disease | Global developmental delay | 5.63e-05 | 133 | 147 | 6 | C0557874 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 7.37e-05 | 3 | 147 | 2 | cv:C3468114 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.05e-04 | 49 | 147 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Schizophrenia | ERBB3 ERBB4 SIGMAR1 CSMD2 ZDHHC8 SLC1A2 PTPRA ARVCF PTPRZ1 SLIT3 OR4C46 CTLA4 ENO2 PLXNA2 | 1.40e-04 | 883 | 147 | 14 | C0036341 |
| Disease | Juvenile amyotrophic lateral sclerosis | 1.47e-04 | 4 | 147 | 2 | C3468114 | |
| Disease | stomach carcinoma (is_marker_for) | 2.27e-04 | 24 | 147 | 3 | DOID:5517 (is_marker_for) | |
| Disease | refractive error | 2.40e-04 | 326 | 147 | 8 | MONDO_0004892 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.44e-04 | 5 | 147 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | laryngeal carcinoma (is_marker_for) | 3.65e-04 | 6 | 147 | 2 | DOID:2600 (is_marker_for) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | BNC2 PRR23A ERBB3 NPR2 COPB1 KIF26B SLC12A8 SIAH3 SF3B1 PRRC2C PAPPA MTCL1 PAX7 SETD3 PLXNA2 WNK2 PDZD2 | 3.99e-04 | 1345 | 147 | 17 | EFO_0010736 |
| Disease | cortical thickness | BNC2 PRR23A ERBB3 NPR2 MDM1 SLC12A8 TM6SF1 SF3B1 MTCL1 PAX7 SETD3 PLXNA2 WNK2 CRB2 PDZD2 | 4.61e-04 | 1113 | 147 | 15 | EFO_0004840 |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | Developmental delay (disorder) | 8.31e-04 | 37 | 147 | 3 | C0424605 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 8.31e-04 | 37 | 147 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 9.71e-04 | 39 | 147 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | retinal vasculature measurement | 1.18e-03 | 517 | 147 | 9 | EFO_0010554 | |
| Disease | oral microbiome measurement | 1.21e-03 | 42 | 147 | 3 | EFO_0801229 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.29e-03 | 43 | 147 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 1.32e-03 | 11 | 147 | 2 | C0016978 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.32e-03 | 11 | 147 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Malignant neoplasm of gallbladder | 1.32e-03 | 11 | 147 | 2 | C0153452 | |
| Disease | macular retinal edema (is_marker_for) | 1.57e-03 | 12 | 147 | 2 | DOID:4449 (is_marker_for) | |
| Disease | hemolysis | 1.67e-03 | 47 | 147 | 3 | EFO_0009473 | |
| Disease | brain measurement, neuroimaging measurement | 1.81e-03 | 550 | 147 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | homostachydrine measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0021164 | |
| Disease | Intellectual Disability | 1.86e-03 | 447 | 147 | 8 | C3714756 | |
| Disease | median neuropathy (biomarker_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | thalamus volume change measurement | 2.16e-03 | 14 | 147 | 2 | EFO_0021496 | |
| Disease | precuneus cortex volume measurement | 2.16e-03 | 14 | 147 | 2 | EFO_0010326 | |
| Disease | hypertension (is_marker_for) | 2.36e-03 | 53 | 147 | 3 | DOID:10763 (is_marker_for) | |
| Disease | Heschl's gyrus morphology measurement | 2.36e-03 | 53 | 147 | 3 | EFO_0005852 | |
| Disease | neuroimaging measurement | PRR23A ERBB3 KIF26B ZDHHC5 SLC12A8 ARHGAP22 APOLD1 PRRC2C PAPPA PAX7 SETD3 PLXNA2 WNK2 | 2.74e-03 | 1069 | 147 | 13 | EFO_0004346 |
| Disease | N-acetyl-beta-alanine measurement | 2.83e-03 | 16 | 147 | 2 | EFO_0021430 | |
| Disease | Amyotrophic Lateral Sclerosis | 3.06e-03 | 58 | 147 | 3 | C0002736 | |
| Disease | Benign neoplasm of stomach | 3.19e-03 | 17 | 147 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.19e-03 | 17 | 147 | 2 | C0496905 | |
| Disease | Amyotrophic lateral sclerosis | 3.19e-03 | 17 | 147 | 2 | cv:C0002736 | |
| Disease | Carcinoma in situ of stomach | 3.19e-03 | 17 | 147 | 2 | C0154060 | |
| Disease | Malignant neoplasm of skin | 3.21e-03 | 59 | 147 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.21e-03 | 59 | 147 | 3 | C0037286 | |
| Disease | chromosomal aberration frequency | 3.58e-03 | 18 | 147 | 2 | EFO_0009860 | |
| Disease | progression free survival, ovarian carcinoma | 3.58e-03 | 18 | 147 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 3.58e-03 | 18 | 147 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | autoimmune thyroid disease | 3.70e-03 | 126 | 147 | 4 | EFO_0006812 | |
| Disease | Stomach Neoplasms | 3.83e-03 | 297 | 147 | 6 | C0038356 | |
| Disease | urate measurement, bone density | 3.96e-03 | 619 | 147 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 3.99e-03 | 19 | 147 | 2 | DOID:2876 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 3.99e-03 | 19 | 147 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.99e-03 | 19 | 147 | 2 | C4721508 | |
| Disease | anorectal malformation | 3.99e-03 | 19 | 147 | 2 | MONDO_0019938 | |
| Disease | Malignant neoplasm of stomach | 4.02e-03 | 300 | 147 | 6 | C0024623 | |
| Disease | carcinoma (implicated_via_orthology) | 4.04e-03 | 64 | 147 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.08e-03 | 301 | 147 | 6 | DOID:684 (is_marker_for) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.42e-03 | 20 | 147 | 2 | C4721952 | |
| Disease | essential tremor | 4.85e-03 | 136 | 147 | 4 | EFO_0003108 | |
| Disease | Stomach Carcinoma | 4.86e-03 | 21 | 147 | 2 | C0699791 | |
| Disease | Arthrogryposis | 4.86e-03 | 21 | 147 | 2 | C0003886 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.86e-03 | 21 | 147 | 2 | C1800706 | |
| Disease | cardiac troponin T measurement | 4.90e-03 | 219 | 147 | 5 | EFO_0005043 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVIALGATLGTATSI | 6 | Q7L8C5 | |
| TSPEIVTALAIAGTL | 491 | Q99798 | |
| ISTADLPVARISAGT | 121 | Q86UN6 | |
| TVLTAALLLSGIPAE | 241 | P49069 | |
| NLATTTLGSALSLPV | 1021 | P21860 | |
| VSLLVAAGTVQPSDS | 11 | Q15303 | |
| RGVPALVALVASSQS | 801 | O00192 | |
| ASVSSSPARALLLVG | 116 | Q8WY22 | |
| LTGFQLPATIVSAAT | 96 | Q7Z408 | |
| LPATIVSAATTLSLR | 101 | Q7Z408 | |
| LPVVSNAAFLTGSIS | 51 | A6NCI8 | |
| SSVGTPLARASIKSA | 436 | Q15878 | |
| LSLVVPSALFAAVGT | 311 | P49419 | |
| IRATSGAATPVIAST | 511 | Q6ZN30 | |
| VILIPVLVSSAGTSA | 6 | Q5VWW1 | |
| VTVSVSTAVPAASAL | 296 | Q86TY3 | |
| VLSLISSLGFNTPIA | 211 | Q96GX5 | |
| VAALLTLPVTLASGA | 176 | Q16570 | |
| LALSSGASLLIVPTS | 251 | Q4L235 | |
| TPLSTLAIVALGTGI | 451 | P20594 | |
| AVLGVPSSLASSVLG | 46 | P21854 | |
| TPIIATLSSGAVAAL | 386 | P52569 | |
| VPLSLFSVAAVAGTV | 986 | A7MBM2 | |
| STIAPALISSGLSVV | 71 | P09104 | |
| ASSILGVFVLTPSLA | 6 | P0CG01 | |
| TISVSLAVAAIPEGL | 296 | P98194 | |
| AAPARVALGITTVLT | 281 | O75311 | |
| ARIPAVTLAVTSVAG | 181 | Q9Y4B5 | |
| STVPSGLVSSISRVL | 146 | P23759 | |
| SLPISENASLGTVIA | 356 | Q9Y5H9 | |
| SLVAAVSIPGNLFSL | 31 | Q86VZ1 | |
| VLATSGIISPSTFAL | 221 | Q96NI6 | |
| TPLLLAATSGALDTI | 641 | Q7Z5J8 | |
| AIVGLSLSPVTLGTS | 101 | Q96LR9 | |
| SLSPVTLGTSLLVSA | 106 | Q96LR9 | |
| LATPITTLGTIATLS | 906 | P51610 | |
| NVSLSTAIVADLGSP | 156 | Q14728 | |
| VALSTLPAGTTGSLV | 2746 | Q8WXI7 | |
| SLSPNLSGTSVEILA | 10071 | Q8WXI7 | |
| LTLTVSPAVSGLSSA | 11891 | Q8WXI7 | |
| VLVAVATALVSASSP | 11 | Q14626 | |
| ASGSAVVLPLARIAT | 21 | P40305 | |
| PRLAAGSSLSITVAS | 1711 | Q86XX4 | |
| ITGSTPVLSSLLANE | 2911 | Q8NEZ4 | |
| AVTSALSPEGVLSIQ | 131 | O14558 | |
| SVLPAASDGQSISLV | 271 | Q9HCI5 | |
| IAASISATPVVSRGA | 1451 | Q5T1H1 | |
| TVAVASGAASTPISI | 1141 | Q6P4R8 | |
| ASPVVAGAVTLLVST | 416 | Q14703 | |
| ALLVLTSPAATLLGS | 546 | O43292 | |
| GLTALSAIAISRTPV | 136 | Q9H3K2 | |
| VASGPVALASTASAT | 546 | Q5IJ48 | |
| PLVLGISLASSLVAS | 416 | P60608 | |
| ALTLLAPAAGDTIIS | 396 | Q16665 | |
| ITVSGSAPVLSAVAT | 316 | P40199 | |
| SAPVLSAVATVGITI | 321 | P40199 | |
| ALASGSRPVSIISSI | 1221 | Q2KJY2 | |
| ILALSATPGSDIKAV | 241 | Q8IYD8 | |
| LTSLALPGKAESVAS | 651 | O15055 | |
| DSLLTLPAIVSIAAG | 1231 | O75051 | |
| VLIVVTITASPSLGS | 41 | A6NHA9 | |
| VSKAISAPLLGSSVD | 1026 | O15018 | |
| GTLVTLSSAPTAIKA | 266 | P53618 | |
| VAISGLLTDQLSSPS | 56 | Q8TDV5 | |
| SRAVSLLTSPAAGIK | 576 | Q8TC05 | |
| TIPSVATATAAALGE | 6 | Q96MW5 | |
| TPLGALSVLVSAILS | 86 | Q8N8Q9 | |
| AIVTLGLAEPSTNIS | 811 | P42704 | |
| DGLTALNISSPVSVA | 1011 | P23471 | |
| DAGTPSLSALTIVRV | 431 | Q9UN70 | |
| AVRVSFSSPLVAISG | 1161 | Q13219 | |
| TPALIFAITVATIGS | 31 | Q8TDB8 | |
| SQAIPLVSVASVAAG | 296 | Q6ZV29 | |
| EASLVAASTGVRALP | 1671 | Q9UG01 | |
| LFTGLASATSAVAPI | 391 | A6NF01 | |
| IILTATLATPSAATV | 1736 | Q5VST9 | |
| SAAGLLPTSILQSTE | 11 | Q8NA29 | |
| TVSLPLKAVEALASG | 56 | O14842 | |
| LVQAAAVSTGPSLEL | 16 | P0C221 | |
| ATPARTALGITTVLT | 281 | Q99928 | |
| AGSIAAVAVTPLDVL | 231 | Q9H1K4 | |
| TATLASVGAASIPSA | 431 | P43004 | |
| AAPSVVLTVGLSAIR | 546 | Q8IVF7 | |
| LVSVPITLALAAAAA | 351 | P26992 | |
| QSLVASSVSPLIVSG | 1196 | Q3T8J9 | |
| LVLAPFTAGTSLALT | 206 | O95236 | |
| TVTLTVLSSPLALAG | 16 | P13762 | |
| AVPFLVSATSGTTVL | 236 | Q9Y600 | |
| ASAAPLGTTLAVQAV | 861 | Q6VMQ6 | |
| LAASVVPTLTEFLAG | 281 | Q99698 | |
| GRVPKSASVSALSLI | 891 | O60307 | |
| TLSSNLGLPVAVSTL | 31 | Q8TEP8 | |
| AQPAVVLASSRGIAS | 41 | P16410 | |
| PVGALSSLAQTEVTL | 176 | Q8TE02 | |
| EGSTSLSAPAVLVVA | 61 | Q9HBU6 | |
| ASTAGPESSLALRLV | 851 | Q9UGM3 | |
| VVALATDPNILSLSG | 236 | Q96LJ7 | |
| AASIPLGSLAAVGIS | 261 | A0AV02 | |
| AASAVTVLLPETLGQ | 496 | Q4U2R8 | |
| TLVTPLGALSVLISA | 141 | Q6NVV3 | |
| PVTAATARTALSGLS | 61 | Q8NAC3 | |
| APSVGITRLINSSTA | 26 | P18433 | |
| AAAAALAAVVTTPLL | 21 | O14654 | |
| PTLALSQVVAAASAL | 1126 | O14654 | |
| ILTSGTLAPVSSFAL | 476 | Q9NZ71 | |
| VVSGTAVTLSLPAVT | 456 | Q92750 | |
| TPAVGALTSIVVLAA | 51 | A6NEV1 | |
| GSAVALVIAPTVLLT | 11 | Q86VH5 | |
| SPTLLSLSLVRTGVT | 51 | Q8N135 | |
| LATFQSAVAILGVPS | 76 | Q9Y289 | |
| LTVPAVLTITFGLSA | 46 | Q6ZW05 | |
| LVVTATASPPAGLLS | 16 | Q6P5W5 | |
| ASVTILASASIPILA | 1851 | Q9Y520 | |
| LASASIPILASALAS | 1856 | Q9Y520 | |
| GVIPSTLAFALADTV | 176 | Q99720 | |
| VLARAGIPTSSVFAL | 356 | Q86TU7 | |
| LAIGIAITATEVLPS | 251 | Q8IW03 | |
| ATPIAASLGDLITLS | 221 | Q96GZ6 | |
| LPTAIAVSSLIAVGT | 156 | Q8N3P4 | |
| AVSGPLAAATASILT | 226 | Q96H78 | |
| AVSLLTAASPTIALL | 931 | Q14160 | |
| TLGVSLSSLGAIPAA | 21 | Q8WXA9 | |
| PISSAVAGVAIGLVT | 501 | Q8TCS8 | |
| LDGAAVAVLSRTAPT | 396 | Q7Z5H3 | |
| PGAFTTLVSLSTINL | 646 | O75094 | |
| SLTAAGSLQVLSLTP | 56 | Q96JI7 | |
| GQVPLTADVLAVSSS | 26 | Q53QW1 | |
| IPAIATTTATVSGLV | 891 | A0AVT1 | |
| VVSSARVAASLPSEG | 76 | A6NEH8 | |
| SAVASVAVDPSGRLL | 801 | O94967 | |
| SPLSVATALSALSLG | 81 | P36955 | |
| GGASSVPLSVLILSL | 656 | O94991 | |
| PAIATTTAAVAGLLG | 851 | P41226 | |
| AALQGTPLSATLSLV | 46 | Q96G75 | |
| SPVSISTTLALLSLG | 76 | Q86U17 | |
| AFAVVASALGIPSLL | 631 | O75533 | |
| TGTPVAAATVAPILA | 371 | Q9H0E3 | |
| SVTAVAALSGRPLGT | 11 | O43674 | |
| SSRALVSTLVPLGLV | 636 | P01833 | |
| LLPGAALTAAVFVAT | 261 | Q86VD9 | |
| IPAIATTTAAVVGLV | 891 | P22314 | |
| PAISSINLTTALGSL | 246 | Q92797 | |
| PVSAAAIFLVGATTL | 16 | Q9C0B5 | |
| SSAAIPFGTLVAILA | 461 | Q99805 | |
| PVATAAALLVGSSTL | 16 | Q9ULC8 | |
| VTASAGSLVLPVLVF | 1701 | Q92508 | |
| AAGITQPLLTLASSA | 866 | Q9H4A3 | |
| LLPAAVGAVSLATSQ | 1536 | Q9Y3S1 | |
| GAIISATDPVTVLAI | 256 | Q96T83 | |
| FTSPAVGSILAAIRA | 81 | Q3LXA3 | |
| VGLLAALSVATPFET | 326 | Q15849 | |
| TVLVASGALFITPTS | 51 | P0DTE4 | |
| GVITTATSPAVALSA | 951 | Q9ULM3 | |
| LTTLATAVTGAALIA | 171 | Q66K66 | |
| FILAPAVGSLTTAAT | 1041 | O95071 | |
| ATGVFVLSLSAIPVT | 6 | Q9BZW5 | |
| ESSSPARGIAIVSVL | 301 | P22459 | |
| GTIVLPARSTTSVLL | 921 | Q9UKN1 | |
| GTIVLPARSTTSVLL | 3561 | Q9UKN1 |